Cancer stem cell vaccine - MedImmune

Drug Profile

Cancer stem cell vaccine - MedImmune

Alternative Names: Cancer stem cell-dendritic cell vaccine; CSC-DC vaccine

Latest Information Update: 19 May 2017

Price : $50

At a glance

  • Originator MedImmune
  • Class Cancer vaccines; Dendritic cell vaccines; Stem cell therapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 01 Apr 2017 Pharmacodynamics data from preclinical studies in Cancer presented at the 108th Annual Meeting of the American Association for Cancer Research (AACR-2017)
  • 16 Apr 2016 Preclinical trials for Cancer in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top